Works by Lusivika-Nzinga, Clovis

Results: 14
    1
    2
    3
    4

    Corrigendum to: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.

    Published in:
    2021
    By:
    • Carrat, Fabrice;
    • Lamballerie, Xavier de;
    • Rahib, Delphine;
    • Blanché, Hélène;
    • Lapidus, Nathanael;
    • Artaud, Fanny;
    • Kab, Sofiane;
    • Renuy, Adeline;
    • Edelenyi, Fabien Szabo de;
    • Meyer, Laurence;
    • Lydié, Nathalie;
    • Charles, Marie-Aline;
    • Ancel, Pierre-Yves;
    • Jusot, Florence;
    • Rouquette, Alexandra;
    • Priet, Stéphane;
    • Villarroel, Paola Mariela Saba;
    • Fourié, Toscane;
    • Lusivika-Nzinga, Clovis;
    • Nicol, Jérôme
    Publication type:
    corrected article
    5

    Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.

    Published in:
    2021
    By:
    • Carrat, Fabrice;
    • Lamballerie, Xavier de;
    • Rahib, Delphine;
    • Blanché, Hélène;
    • Lapidus, Nathanael;
    • Artaud, Fanny;
    • Kab, Sofiane;
    • Renuy, Adeline;
    • Edelenyi, Fabien Szabo de;
    • Meyer, Laurence;
    • Lydié, Nathalie;
    • Charles, Marie-Aline;
    • Ancel, Pierre-Yves;
    • Jusot, Florence;
    • Rouquette, Alexandra;
    • Priet, Stéphane;
    • Villarroel, Paola Mariela Saba;
    • Fourié, Toscane;
    • Lusivika-Nzinga, Clovis;
    • Nicol, Jérôme
    Publication type:
    journal article
    6

    Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients.

    Published in:
    Journal of Viral Hepatitis, 2023, v. 30, n. 6, p. 567, doi. 10.1111/jvh.13830
    By:
    • Moreau, Clémence;
    • Roux, Marine;
    • Riou, Jérémie;
    • Canivet, Clémence M.;
    • Audureau, Etienne;
    • Lusivika‐Nzinga, Clovis;
    • Nahon, Pierre;
    • Carrat, Fabrice;
    • Boursier, Jérôme;
    • Nahon, P.;
    • Layese, R.;
    • Audureau, E.;
    • Bedossa, P.;
    • Bonjour, M.;
    • Bourcier, V.;
    • Dharancy, S.;
    • Durand‐Zaleski, I.;
    • Fontaine, H.;
    • Guyader, D.;
    • Laurent, A.
    Publication type:
    Article
    7
    8

    Sofosbuvir‐Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real‐life experience from the HEPATHER ANRS CO22 cohort.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 10, p. 964, doi. 10.1111/jvh.13321
    By:
    • Lédinghen, Victor;
    • Lusivika‐Nzinga, Clovis;
    • Bronowicki, Jean‐Pierre;
    • Zoulim, Fabien;
    • Larrey, Dominique;
    • Metivier, Sophie;
    • Tran, Albert;
    • Marcellin, Patrick;
    • Samuel, Didier;
    • Chazouillères, Olivier;
    • Chevaliez, Stephane;
    • Dorival, Celine;
    • Fontaine, Hélène;
    • Pawlotsky, Jean‐Michel;
    • Carrat, Fabrice;
    • Pol, Stanislas
    Publication type:
    Article
    9
    10
    11

    Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).

    Published in:
    Quality of Life Research, 2023, v. 32, n. 12, p. 3427, doi. 10.1007/s11136-023-03496-w
    By:
    • Carrieri, Patrizia;
    • Bourlière, Marc;
    • Di Beo, Vincent;
    • Lusivika-Nzinga, Clovis;
    • Ramier, Clémence;
    • Antwerpes, Saskia;
    • Protopopescu, Camelia;
    • Lacombe, Jean-Marc;
    • Pol, Stanislas;
    • Fontaine, Hélène;
    • Mourad, Abbas;
    • Carrat, Fabrice;
    • Duracinsky, Martin;
    • Marcellin, Fabienne;
    • Alric, Laurent;
    • Bonnet, Delphine;
    • Camou, Océane;
    • Zoulim, Fabien;
    • Maynard, Marianne;
    • Bailly, François
    Publication type:
    Article
    12

    Publisher Correction: Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population.

    Published in:
    2022
    By:
    • Carrat, Fabrice;
    • Villarroel, Paola Mariela Saba;
    • Lapidus, Nathanael;
    • Fourié, Toscane;
    • Blanché, Hélène;
    • Dorival, Céline;
    • Nicol, Jérôme;
    • Deleuze, Jean-François;
    • Robineau, Olivier;
    • SAPRIS-SERO Study Group;
    • Zins, Marie;
    • Severi, Gianluca;
    • Touvier, Mathilde;
    • de Lamballerie, Xavier;
    • Lusivika-Nzinga, Clovis;
    • Pannetier, Gregory;
    • Goderel, Isabelle;
    • Kab, Sofiane;
    • Renuy, Adeline;
    • Le-Got, Stéphane
    Publication type:
    Correction Notice
    13

    Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11787-4
    By:
    • Carrat, Fabrice;
    • Villarroel, Paola Mariela Saba;
    • Lapidus, Nathanael;
    • Fourié, Toscane;
    • Blanché, Hélène;
    • Dorival, Céline;
    • Nicol, Jérôme;
    • Deleuze, Jean-François;
    • Robineau, Olivier;
    • SAPRIS-SERO Study Group;
    • Zins, Marie;
    • Severi, Gianluca;
    • Touvier, Mathilde;
    • de Lamballerie, Xavier;
    • Lusivika-Nzinga, Clovis;
    • Pannetier, Gregory;
    • Goderel, Isabelle;
    • Kab, Sofiane;
    • Renuy, Adeline;
    • Le-Got, Stéphane
    Publication type:
    Article
    14

    Heterogeneous SARS-CoV-2 humoral response after COVID-19 vaccination and/or infection in the general population.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11787-4
    By:
    • Carrat, Fabrice;
    • Villarroel, Paola Mariela Saba;
    • Lapidus, Nathanael;
    • Fourié, Toscane;
    • Blanché, Hélène;
    • Dorival, Céline;
    • Nicol, Jérôme;
    • Deleuze, Jean-François;
    • Robineau, Olivier;
    • SAPRIS-SERO Study Group;
    • Zins, Marie;
    • Severi, Gianluca;
    • Touvier, Mathilde;
    • de Lamballerie, Xavier;
    • Lusivika-Nzinga, Clovis;
    • Pannetier, Gregory;
    • Goderel, Isabelle;
    • Kab, Sofiane;
    • Renuy, Adeline;
    • Le-Got, Stéphane
    Publication type:
    Article